Brian VanderBeek, MD, MPH, MSCE
Assistant Professor of Ophthalmology at the Hospital of the University of Pennsylvania
Department: Ophthalmology
Contact information
Scheie Eye Institute
51 N. 39th Street
Philadelphia, PA 19104
51 N. 39th Street
Philadelphia, PA 19104
Publications
Education:
BA (Biology)
University of Michigan, School of Literature, Science & Arts, 1999.
MPH (Toxicology)
University of Michigan, School of Public Health, 2001.
MD
University of Cincinnati College of Medicine, 2005.
MSCE
University of Pennsylvania School of Medicine, 2015.
Permanent linkBA (Biology)
University of Michigan, School of Literature, Science & Arts, 1999.
MPH (Toxicology)
University of Michigan, School of Public Health, 2001.
MD
University of Cincinnati College of Medicine, 2005.
MSCE
University of Pennsylvania School of Medicine, 2015.
Description of Clinical Expertise
Diabetic RetinopathyAge-related Macular Degeneration
Retinal Vein Occlusion
Description of Research Expertise
EpidemiologyObservational study design
Big data analysis
Selected Publications
Randy Dotinga: No Difference in Kidney Failure Risk Between Three Anti-VEGF Agents for Eye Disease. MedPage Today Apr 2024 Notes: https://www.medpagetoday.com/ophthalmology/generalophthalmology/109592.VanderBeek BL, Yu Y, Oden N, VanVeldhuisen P, Blodi B, Ip M, Scott IU. : Visit Adherence and Visual Acuity in Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2). Ophthalmic Epidemiol 31(1): 78-83, Feb 2024.
Kate Kneisel: Bacterial Infection Outbreak After Double Cataract Surgery Tied to Sterility Breach. Medpage Today Oct 2023 Notes: https://www.medpagetoday.com/ophthalmology/generalophthalmology/106975
Lauren Dembeck PhD : Herpes Zoster Ophthalmicus Elevates Stroke Risk. Optometry Advisor Oct 2023 Notes: https://www.optometryadvisor.com/general-optometry/herpes-zoster-ophthalmicus-increases-the-risk-of-stroke/
Nadelmann JB, Miller CG, McGeehan B, Yu Y, VanderBeek BL: SGLT2 inhibitors and diabetic retinopathy progression. Graefes Arch Clin Exp Ophthalmol Oct 2023 Notes: Link: https://link.springer.com/article/10.1007/s00417-023-06273-0.
Gupta AS, Yu Y, Orlin S, VanderBeek BL: Real world socioeconomic determinants of corneal crosslinking in a national cohort J Cataract Refract Surg Epub ahead of print, Oct 2023 Notes: Link : https://journals.lww.com/jcrs/fulltext/2024/03000/real_world_socioeconomic_determinants_of_corneal.4.aspx.
Kate Kneisel: Demand for Anti-VEGF Injections for Retinal Diseases Expected to Surge. Medpage Today Oct 2023 Notes: https://www.medpagetoday.com/ophthalmology/generalophthalmology/106689.
Nadelmann JB, Li Y, McGeehan B, Yu Y, VanderBeek BL. : Systemic disease associations with angioid streaks in a large healthcare claims database. Eye (Lond) 37(8): 1596-1601, Aug 2023.
Tsui JC, Willett K, Cohen JB, Yu Y, VanderBeek BL: Erythropoiesis-Stimulating Agents and the Risk of Vision-Threatening Diabetic Retinopathy. Ophthalmic Epidemiol Epub ahead of print, July 2023.
Kate Kniesel: Anti-VEGF Injections for Diabetic Retinopathy Linked to Systemic Adverse Events. Medpage Today June 2023 Notes: https://www.medpagetoday.com/ophthalmology/generalophthalmology/104814.